P Andrew Futreal

AACR Cancer Progress Report 2012

Stuart L Schreiber, Lewis C Cantley, Todd R Golub, 2012, Clinical Cancer Research.

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nazneen Rahman, Carel Meijers, Julian Peto, 2002, Nature Genetics.

BRAF and RAS mutations in human lung cancer and melanoma.

Richard Wooster, Helen Davies, Michael R Stratton, 2002, Cancer research.

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

Nazneen Rahman, Carel Meijers, Sheila Seal, 2003, American journal of human genetics.

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Celette Sugg Skinner, Barbara K Rimer, Brian Calingaert, 2002, Genetic testing.

Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.

Daniel Gomez, Lynda Chin, Koichi Takahashi, 2018, The oncologist.